After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Relay Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Relay Therapeutics Inc is $525.52M. A total of 2.59 million shares were traded on the day, compared to an average of 2.25M shares.
In the most recent transaction, Patel Sanjiv sold 140,182 shares of RLAY for 3.85 per share on Feb 11 ’25. After the transaction, the President and CEO now owns 625,948 company shares. In a previous transaction on Feb 13 ’25, Patel Sanjiv sold 75,324 shares at 3.70 per share. RLAY shares that President and CEO owns now total 883,089.
Among the insiders who sold shares, Rahmer Peter disposed of 26,541 shares on Jan 29 ’25 at a per-share price of $4.55. This resulted in the insider holding 419,681 shares of RLAY after the transaction. In another insider transaction, Rahmer Peter sold 17,250 shares at $4.42 per share on Jan 30 ’25. Company shares held by the insider now total 402,431.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, RLAY has a high of $10.72 and a low of $3.02.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. RLAY’s latest balance sheet shows that the firm has $958.07M in Cash & Short Term Investments as of fiscal 2021. There were $22.90M in debt and $24.32M in liabilities at the time. Its Book Value Per Share was $4.64, while its Total Shareholder’s Equity was $897.81M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RLAY is Buy with a score of 4.85.
